Nasdaq

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Monthly Prescribing Reference

Dexcom Stelo Biosensor Cleared as First OTC Continuous Glucose Monitor

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...
FierceBiotech

Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...
Business Wire

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
VentureBeat

Dexcom Stelo is the 1st glucose monitor for those with prediabetes condition

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
Monthly Prescribing Reference

Stelo OTC Wearable Glucose Biosensor Now Available

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...
San Diego Union-Tribune

Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
Benzinga.com

FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...
CNBC

Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
San Diego Union-Tribune

San Diego’s Dexcom gets first FDA clearance for an over-the-counter wearable continuous glucose monitor

San Diego device maker Dexcom has received the first FDA clearance for a continuous glucose monitor that doesn’t require a doctor’s prescription. The U.S. Food and Drug Administration cleared Dexcom’s ...
Nasdaq

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...